Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cyclerion Therapeutics Inc

CYCN
Current price
2.21 USD -0.64 USD (-22.46%)
Last closed 2.79 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 5 524 116 USD
Yield for 12 month -51.75 %
1Y
3Y
5Y
10Y
15Y
CYCN
21.11.2021 - 28.11.2021

Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to out-license for cardiovascular diseases; and Praliciguat, a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. Address: 245 First Street, Riverview II, Cambridge, MA, United States, 02142

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4 USD

P/E ratio

Dividend Yield

Current Year

Last Year

+297 000 USD

Current Quarter

Last Quarter

Current Year

Last Year

+232 000 USD

Current Quarter

Last Quarter

Key Figures CYCN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -9 582 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -43.77 %
PEG Ratio
Return On Equity TTM -158.12 %
Wall Street Target Price 4 USD
Revenue TTM 1 328 000 USD
Book Value 3.97 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 14.1 %
Dividend Yield
Gross Profit TTM -29 749 000 USD
Earnings per share -4.55 USD
Diluted Eps TTM -4.55 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CYCN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CYCN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 16.05.2023
Dividend Date

Stock Valuation CYCN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.517
Price Sales TTM 55.5007
Enterprise Value EBITDA -0.1619
Price Book MRQ 0.8091

Financials CYCN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CYCN

For 52 weeks

1.75 USD 5.25 USD
50 Day MA 2.86 USD
Shares Short Prior Month 18 566
200 Day MA 3.07 USD
Short Ratio 18.44
Shares Short 17 835
Short Percent 1.13 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

446.34 USD Microsoft Corporation -3.37 (-0.75%)
Detailed analytics

ETF funds


S

SLICHA

203.95 CHF UBS SLI A-dis -0.06 (-0.02%)
Detailed analytics

Metals


Gold

2339.94 USD Gold +11.09 (+0.48%)
Detailed analytics